USNA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $14.82
Market Cap (MRQ) $274M
P/E (TTM) -7.1
EPS (TTM) $-2.10
Revenue (TTM) $927M
ROE (TTM) -7.4%
52W Range $13–$28

USNA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 3
Ex-date Split Type
Nov. 23, 2016 2-for-1 Forward
Oct. 31, 2003 2-for-1 Forward
Aug. 4, 1998 2-for-1 Forward

About USANA Health Sciences, Inc. Common Stock Company overview from Wikipedia

05 · wikidata

USANA Health Sciences, Inc., or USANA, is an American direct sales company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

History

In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its brand partnersor by direct order through the company.

On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.

In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.

USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.

In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.

By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. In 2026, the Kids Eat program continued efforts to address childhood food insecurity in Utah by providing food bags to students and allowing businesses, families, and other organizations to sponsor participating schools. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.

The USANA Foundation was founded in 2012 and has provided hundreds of millions of meals in more than 45 countries. Their programs include USANA Kids Eat and the USANA Garden Towers.

In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.

In 2024, USANA acquired a 79% stake in children's health and wellness company Hiya Health in a $260 million transaction, making Hiya a subsidiary of USANA. At the time of the acquisition, Hiya had grown to approximately $100 million in annual sales and offered eight children's health products, including multivitamins, probiotics, iron supplements, and immune support products.

Corporate affairs

Leadership

In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.

Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.

Operations

USANA, a multilevel marketing company, sells its products primarily through non-employee Brand Partners, as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.

Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".

USANA sells nutritional, personal care, and food products through Brand Partners and online channels.

USANA classifies Brand Partners and Preferred Customers in its core nutritional business as active customers. There were 387,000 active customers as of January 2026. In 2025, Brand Partners and Preferred Customers each made up about half of all active customers.

Sponsorships

USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.

In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season. USANA provided its products to 40 athletes at the Turin Olympics and worked with various sports organizations, including the Professional Rodeo Cowboys Association.

In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.

In 2020, USANA became the title partner of U.S. Ski & Snowboard's training and education facility, the Center of Excellence. The facility is a training hub used by Olympians, youth athletes, and various international competitions.

In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.

Products

USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).

USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

USANA began using InCelligence Technology in August 2016 and registered it as a U.S. trademark in March 2017. The technology is used in the company's CellSentials nutritional supplement system, including its Core Minerals and Vita-Antioxidant products, which USANA markets as using its InCelligence Complex to support cellular protection and renewal. As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.

Reception

From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.

John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".

New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

sectorConsumer products industryConsumer products employees1,570 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$925M
2016-12-31 → 2026-01-03
EPS$0.58
2016-12-31 → 2026-01-03
Free Cash Flow$9M
2016-12-31 → 2026-01-03
Net margin-4.2%
2016-12-31 → 2026-01-03
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend USNA 5Y avg Peer Median Verdict
P/E (TTM) -7.15Y avg ≈19.7 ≈19.7 · ·
P/S (TTM) 0.35Y avg ≈1.0 ≈1.0 1.2 Undervalued
P/B (MRQ) 0.55Y avg ≈2.3 ≈2.3 2.4 Undervalued
Price / FCF (TTM) -16.85Y avg ≈20.5 ≈20.5 · ·
Price / Cash Flow (TTM) -157.25Y avg ≈13.5 ≈13.5 16.8 Fair value
Price / Tangible Book (MRQ) 0.75Y avg ≈3.0 ≈3.0 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -21.9%
Next Report Oct 19, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Jul 20, 2026 $-0.07 $0.44 -116.0%
March 31, 2026 $0.61 $0.45 35.9%
Dec. 31, 2025 $0.60 $0.42 43.5%
Sept. 30, 2025 $-0.15 $0.48 -131.3%
June 30, 2025 $0.74 $0.55 34.4%
March 31, 2025 $0.73 $0.71 2.2%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 18
Metric Trend 202520242023202220212020201920182017201620152014
Revenue $925M$855M$921M$999M$1.19B$1.13B$1.06B$1.19B$1.05B$1.01B$918M$790M
Cost of Revenue $201M$161M$177M$194M$218M$209M$188M$201M$179M$180M$160M$141M
Gross Profit $724M$693M$744M$805M$969M$926M$873M$989M$868M$826M$759M$650M
R&D Expense $11M$12M$11M$12M$11M$11M$10M$10M$9M$9M$6M$5M
SG&A Expense $337M$263M$257M$262M$279M$261M$268M$275M$265M$234M$209M$185M
Operating Expenses $687M$627M$651M$697M$798M$749M$727M$800M$735M$687M$617M$534M
Operating Income $37M$66M$93M$108M$170M$176M$146M$188M$133M$139M$142M$116M
Interest Expense ··$262.0K$192.0K$57.0K$507.0K$66.0K$36.0K$46.0K$444.0K$15.0K$129.0K
Interest Income $2M$11M$10M$4M$3M$3M$5M$4M$2M$1M$1M$500.0K
Other Non-op $3M$-1M$7.0K$-3M$-2M$-571.0K$-335.0K$-1M$-3.0K$-1M$-174.0K$-820.0K
Pretax Income $42M$76M$102M$109M$171M$178M$150M$192M$135M$139M$143M$116M
Income Tax $30M$34M$39M$39M$54M$53M$50M$65M$72M$39M$48M$39M
Net Income $11M$42M$64M$69M$117M$125M$101M$126M$63M$100M$95M$77M
EPS (Basic) $0.58$2.20$3.31$3.60$5.78$5.89$4.44$5.24$2.57$4.14$3.72$2.90
EPS (Diluted) $0.58$2.19$3.30$3.59$5.73$5.86$4.41$5.12$2.53$3.99$3.59$2.80
Shares (Basic) 18,535,00019,103,00019,250,00019,254,00020,146,00021,156,00022,644,00024,105,00024,349,00024,185,00025,460,00026,443,000
Shares (Diluted) 18,574,00019,162,00019,345,00019,310,00020,343,00021,256,00022,818,00024,642,00024,708,00025,047,00026,355,00027,377,000
EBITDA $70M$81M$106M$121M$183M$190M$161M$205M$149M$152M$152M$125M
Balance Sheet 26
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $158M$182M$330M$288M$240M$312M$235M$214M$247M$176M$143M$111M
Receivables $4M···········
Inventory $103M$70M$61M$67M$98M$90M$69M$82M$63M$65M$66M$45M
Prepaid Expense $23M$28M$26M$29M$27M$23M$26M$33M$30M$37M$35M$35M
Other Current Assets $5M$5M$6M$7M$4M$5M$5M$7M$5M$6M$5M$6M
Current Assets $288M$279M$418M$384M$365M$425M$329M$392M$340M$278M$244M$191M
PP&E (Net) $94M$95M$100M$98M$102M$100M$95M$92M$103M$101M$88M$71M
PP&E (Gross) ··$212M$210M$211M$199M$181M$178M$177M$164M$120M$114M
Accum. Depreciation $135M$130M$129M$125M$122M$116M$105M$96M$86M$76M$71M$64M
Goodwill $138M$144M$17M$17M$18M$17M$17M$17M$17M$17M$17M$18M
Intangibles $133M$152M$30M$32M$30M$31M$30M$32M$35M$34M$38M$41M
Other Non-current Assets $62M$59M$55M$55M$58M$62M$43M$18M$21M$22M$25M$24M
Total Assets $743M$748M$633M$597M$578M$641M$517M$554M$519M$471M$423M$351M
Accounts Payable $17M$12M$10M$11M$14M$18M$13M$10M$12M$9M$10M$8M
Accrued Liabilities $10M$14M$10M·········
Current Liabilities $129M$140M$119M$144M$161M$168M$136M$149M$141M$138M$131M$109M
Capital Leases $12M$10M$5M$8M$10M·$17M·····
Deferred Tax $5M$4M$5M$4M$7M$12M$10M$13M$14M$5M$10M$11M
Other Non-current Liabilities $23M$18M$12M$14M$14M$19M$19M$1M$1M$1M$1M$1M
Total Liabilities $157M$162M$136M·········
Common Stock $18.0K$19.0K$19.0K$19.0K$19.0K$21.0K$22.0K$24.0K$24.0K$24.0K$25.0K$13.0K
Retained Earnings $466M$479M$445M$392M$345M$383M$306M$330M$288M$265M$215M$166M
AOCI $-16M$-23M$-14M$-13M$458.0K$-4M$-14M$-10M$-1M$-12M$-4M$2M
Stockholders' Equity $533M$532M$497M$434M$395M$442M$352M$391M$363M$325M$281M$230M
Liabilities + Equity $743M$748M$633M$597M$578M$641M$517M$554M$519M$471M$423M$351M
Shares Outstanding 18,281,00019,064,00019,130,00019,206,00019,393,00021,038,00021,655,00023,567,00024,024,00024,485,00024,976,00025,266,000
Cash Flow 16
Metric Trend 202520242023202220212020201920182017201620152014
D&A $33M$15M$13M$13M$13M$14M$15M$17M$16M$13M$10M$9M
Stock-based Comp $14M$15M$15M$13M$14M$14M$16M$15M$15M$17M$11M$10M
Deferred Tax $-7M$-7M$-3M$-7M$-3M$-2M$-4M$607.0K$19M$-4M$-3M$-1M
Amort. of Intangibles $19M$2M$2M$2M$1M$1M$1M$2M$1M$2M$900.0K$431.0K
Restructuring $6M$0$0·········
Other Non-cash $-28M$-3M$-18M$15M$-20M$10M$-442.0K$-7M$10M$11M$-2M$11M
Operating Cash Flow $22M$61M$71M$104M$121M$160M$127M$152M$124M$137M$111M$105M
CapEx $14M$10M$14M$10M$13M$15M$17M$11M$13M$33M$24M$20M
Investing Cash Flow $-10M$-213M$-12M$-12M$-14M$-34M$47M$-69M$-13M$-32M$-25M$-16M
Stock Repurchased $28M$9M$12M$25M$178M$57M$150M$105M$50M$65M$61M$139M
Net Stock Activity $-28M$-9M$-12M$-25M$-178M$-57M$-150M$-105M$-50M$-65M$-61M$-139M
Financing Cash Flow $-41M$10M$-14M$-30M$-181M$-59M$-152M$-105M$-50M$-65M$-49M$-113M
Net Change in Cash $-23M$-149M$42M$48M$-72M$78M$20M$-33M$72M$32M$32M$-26M
Taxes Paid $37M$40M$42M·········
Free Cash Flow $9M$51M$56M$94M$108M$145M$110M$141M$111M$104M$88M$85M
Levered FCF ··$56M$93M$108M$145M$110M$141M$111M$104M$88M$85M
Profitability 8
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 78.3%81.1%80.8%80.6%81.6%81.6%82.3%83.1%82.9%82.1%82.6%82.2%
Operating Margin 4.0%7.8%10.1%10.8%14.3%15.6%13.8%15.8%12.7%13.8%15.4%14.7%
Net Margin 1.2%4.9%6.9%6.9%9.8%11.0%9.5%10.6%6.0%9.9%10.3%9.7%
Pretax Margin 4.5%8.9%11.1%10.9%14.4%15.7%14.2%16.1%12.9%13.8%15.5%14.6%
EBITDA Margin 7.6%9.5%11.5%12.1%15.4%16.8%15.2%17.2%14.2%15.1%16.5%15.8%
ROA 1.4%6.1%10.4%11.8%19.1%21.5%18.8%23.5%12.6%22.4%24.5%21.3%
ROE 2.0%7.9%13.2%16.4%29.3%30.0%30.2%30.5%17.2%33.0%37.0%31.2%
ROIC 1.9%6.9%11.7%15.8%29.4%28.0%27.8%31.7%16.9%30.8%33.5%33.4%
Liquidity & Solvency 3
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 2.22.03.52.72.32.52.42.62.42.01.91.8
Quick Ratio 1.21.32.82.01.51.91.71.41.81.31.11.0
Interest Coverage ··355.2560.52985.8348.12215.05232.02880.5312.29444.1900.0
Efficiency 2
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 1.21.21.51.71.92.02.02.22.12.32.42.2
Inventory Turnover 2.32.52.72.32.32.22.52.82.82.82.93.0
Per Share 5
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share $29.16$27.91$25.99$22.62$20.37$20.99$16.24$16.60$15.12$13.29$22.49$18.22
Revenue / Share $49.81$44.59$47.61$51.71$58.32$53.38$46.49$48.26$42.39$40.17$69.70$57.74
Cash Flow / Share $1.20$3.18$3.65$5.38$5.96$7.55$5.55$6.17$5.01$5.47$8.46$7.68
Cash / Share $8.66$9.53$17.27$15.02$12.37$14.83$10.84$9.09$10.29$7.18$11.47$8.80
EPS (TTM) $0.58$2.19$3.30$3.59$5.73$5.86$4.41$5.12$2.53$3.99$3.59$2.80
Growth Rates 9
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 8.3%-7.2%-7.8%-15.8%4.6%·······
Revenue CAGR 3Y -2.5%-10.4%-6.7%·········
Revenue CAGR 5Y -4.0%···········
EPS YoY -73.5%-33.6%-8.1%-37.4%-2.2%·······
EPS CAGR 3Y -45.5%-27.4%-17.4%·········
EPS CAGR 5Y -37.0%···········
Net Income YoY -74.4%-34.1%-8.0%-40.5%-6.5%·······
Net Income CAGR 3Y -46.3%-28.8%-20.0%·········
Net Income CAGR 5Y -38.7%···········
Valuation (TTM) 10
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM $925M$855M$921M$999M$1.19B$1.13B$1.06B$1.19B$1.05B$1.01B$918M$790M
Net Income TTM $11M$42M$64M$69M$117M$125M$101M$126M$63M$100M$95M$77M
Market Cap $355M$680M$1.03B$1.02B$1.96B$1.62B$1.73B$2.71B$1.78B$1.50B$798M$646M
P/E 33.516.316.214.817.713.218.122.529.315.317.818.3
P/S 0.40.81.11.01.71.41.62.31.71.50.90.8
P/B 0.71.32.12.45.03.74.96.94.94.62.82.8
P / Tangible Book 1.42.92.32.75.74.1······
P / Cash Flow 15.911.214.59.816.210.113.717.814.410.97.26.1
P / FCF 41.713.418.310.918.111.215.719.316.114.49.17.6
Earnings Yield 3.0%6.1%6.2%6.8%5.7%7.6%5.5%4.5%3.4%6.5%5.6%5.5%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2026-01-032024-12-282023-12-302022-12-312022-01-01
Revenue $925M $855M $921M $999M $1.19B
Gross Margin % 78.3% 81.1% 80.8% 80.6% 81.6%
Operating Margin % 4.0% 7.8% 10.1% 10.8% 14.3%
Net Income $11M $42M $64M $69M $117M
Diluted EPS $0.58 $2.19 $3.30 $3.59 $5.73

Institutional owners (13F) 151 filers · $260.7M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 151
Value held $260.7M
New positions 25
Exited positions 17
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
25 (-5 vs prior Q) 17 (+8 vs prior Q) 60 (+21 vs prior Q) 30 (-19 vs prior Q) +1.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
BlackRock, Inc. $33,181,935 1,554,189 12.73% Shares
PZENA INVESTMENT MANAGEMENT LLC $25,739,282 1,205,587 9.87% Shares
RENAISSANCE TECHNOLOGIES LLC $20,464,402 958,520 7.85% Shares
VANGUARD GROUP INC $18,340,623 934,316 7.03% Shares
DIMENSIONAL FUND ADVISORS LP $17,878,705 837,426 6.86% Shares
Nantahala Capital Management, LLC $17,295,080 810,074 6.63% Shares
VANGUARD CAPITAL MANAGEMENT LLC $10,405,350 487,370 3.99% Shares
Creative Planning $8,923,681 417,971 3.42% Shares
AQR CAPITAL MANAGEMENT LLC $8,712,637 408,086 3.34% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $7,758,099 363,377 2.98% Shares
GEODE CAPITAL MANAGEMENT, LLC $6,047,019 283,165 2.32% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $5,811,641 272,208 2.23% Shares
STATE STREET CORP $5,577,474 261,240 2.14% Shares
Nuveen, LLC $5,112,835 239,477 1.96% Shares
AMERICAN CENTURY COMPANIES INC $3,999,880 187,348 1.53% Shares
JACOBS LEVY EQUITY MANAGEMENT, INC $3,855,105 180,567 1.48% Shares
TWO SIGMA INVESTMENTS, LP $3,533,724 165,514 1.36% Shares
MORGAN STANLEY $3,509,150 164,363 1.35% Shares
D. E. Shaw & Co., Inc. $3,348,427 156,835 1.28% Shares
Allianz Asset Management GmbH $3,040,219 142,399 1.17% Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC $2,949,567 138,153 1.13% Shares
ALGERT GLOBAL LLC $2,813,033 131,758 1.08% Shares
GOLDMAN SACHS GROUP INC $2,631,750 123,267 1.01% Shares
UBS Group AG $2,474,166 115,886 0.95% Shares
LAZARD ASSET MANAGEMENT LLC $2,077,590 97,311 0.80% Shares
NORTHERN TRUST CORP $2,016,870 94,467 0.77% Shares
AMERIPRISE FINANCIAL INC $1,552,893 72,735 0.60% Shares
VANGUARD FIDUCIARY TRUST CO $1,549,540 72,578 0.59% Shares
Vanguard Global Advisers, LLC $1,514,569 70,940 0.58% Shares
Empowered Funds, LLC $1,499,902 70,253 0.58% Shares
TWO SIGMA ADVISERS, LP $1,289,691 65,700 0.49% Shares
Bank of New York Mellon Corp $1,104,521 51,734 0.42% Shares
Quantinno Capital Management LP $1,072,261 50,223 0.41% Shares
BANK OF AMERICA CORP /DE/ $967,539 45,318 0.37% Shares
ROYCE & ASSOCIATES LP $884,039 41,407 0.34% Shares
DEUTSCHE BANK AG\ $821,975 38,500 0.32% Shares
Assenagon Asset Management S.A. $815,848 38,213 0.31% Shares
BARCLAYS PLC $777,141 36,400 0.30% Shares
STRS OHIO $723,765 33,900 0.28% Shares
Skopos Labs, Inc. $673,696 38,563 0.26% Shares
HSBC HOLDINGS PLC $672,758 31,960 0.26% Shares
Invesco Ltd. $670,775 31,418 0.26% Shares
SEI INVESTMENTS CO $641,513 30,047 0.25% Shares
XTX Topco Ltd $625,320 29,289 0.24% Shares
CITADEL ADVISORS LLC $575,617 26,961 0.22% Shares
MILLENNIUM MANAGEMENT LLC $570,728 26,732 0.22% Shares
Verdad Advisers, LP $556,552 26,068 0.21% Shares
Inspire Investing, LLC $512,954 29,362 0.20% Shares
Sanctuary Advisors, LLC $497,113 23,284 0.19% Shares
Man Group plc $489,854 22,944 0.19% Shares

Show all 151 institutional owners →

Activists & 5%+ owners 3 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Gull Global Limited, Myron W. Wentz ×11 filings March 30, 2026 40.10% Amendment M&A / sale SEC
Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust May 23, 2008 · Initial filing · SEC
Paul & Jane Meyer Family Foundation May 20, 2008 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 38 insiders · 20 officers · 13 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Jim Brown CEO & PRESIDENT July 24, 2025 M 16,934 0 0 $0
Doug G Iiekking CHIEF FINANCIAL OFFICER May 27, 2026 S 0 0 1 $-100,500
Jeffrey Yates Chief Financial Officer Oct. 28, 2010 M 0 0 0 $0
Deborah Woo President of Asia Sept. 8, 2016 M 1,479 0 0 $0
Fred W Cooper President and COO Oct. 28, 2010 M 0 0 0 $0
Walter Noot CHIEF OPERATING OFFICER Feb. 27, 2026 M 9,256 0 0 $0
Roy Truett Chief Operating Officer July 27, 2012 M 0 0 0 $0
Kathryn Michelle Armstrong CHIEF SCIENTIFIC OFFICER July 25, 2026 M 3,471 0 0 $0
Peter Benedict CHIEF INFORMATION OFFICER July 25, 2026 M 422 0 2 $-144,236
Brent Neidig CHIEF COMMERCIAL OFFICER June 16, 2026 S 0 0 3 $-147,749
Paul A. Jones CHIEF PEOPLE OFFICER June 8, 2026 S 0 0 2 $-231,984
Joshua Foukas CHIEF LEGAL OFFICER May 7, 2026 S 0 0 2 $-170,336
David Mulham Mulham CHIEF SALES OFFICER Dec. 10, 2025 S 8,387 0 1 $-18,333
Daniel A. Macuga CHIEF COMMUNICATIONS OFFICER May 2, 2024 S 0 0 0 $0
Robert A Sinnott CHIEF SCIENTIFIC OFFICER March 5, 2024 S 0 0 0 $0
James Bramble Chief Legal Officer and Sec Feb. 5, 2018 A 2,076 0 0 $0
Dave Wentz Co-C.E.O. Aug. 16, 2016 M 384,883 0 0 $0
Rick Stambaugh Chief Information Officer Dec. 17, 2015 M 0 0 0 $0
Mark H Wilson E.V.P. of Sales Oct. 28, 2010 M 5,000 0 0 $0
Bradford Richardson E.V.P. of Asia Pacific Feb. 25, 2008 S 0 0 0 $0
Xia Ding Director July 23, 2026 M 8,278 0 0 $0
John Turman Fleming Director July 23, 2026 M 5,862 0 2 $-78,560
Peggie Pelosi Director July 23, 2026 M 6,061 0 0 $0
Scott J Nixon Director July 23, 2026 M 11,445 0 0 $0
Frederic J Winssinger Director July 23, 2026 M 9,733 0 1 $-38,420
Timothy E Wood Director July 23, 2026 M 11,837 0 0 $0
Gilbert A Fuller Director July 23, 2026 M 1,632 0 3 $-60,414
Robert Auciaux Director May 9, 2022 M 8,092 0 0 $0
Feng Peng Director April 28, 2021 M 755 0 0 $0
Myron W. Wentz Director Feb. 4, 2019 S 9,865,614 0 0 $0
Jerry G Mcclain Director March 4, 2016 M 0 0 0 $0
Ronald S Poelman Director Feb. 8, 2016 A 0 0 0 $0
Denis E Waitley Director Nov. 3, 2006 M 0 0 0 $0
Gull Global Limited 10% owner Feb. 4, 2019 S 9,865,614 0 0 $0
GULL HOLDINGS LTD 10% owner April 1, 2015 J 6,491,110 0 0 $0
Kevin Guest · Feb. 27, 2026 M 45,381 0 0 $0
Donald R. Williams · May 1, 2017 A · 0 0 $0
Doug Braun · Dec. 16, 2015 M 0 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 22 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VFVA · VANGUARD WELLINGTON FUND 0.11% 45,046 SH Aug. 19, 2026 Daily
EBIT · Harbor ETF Trust 0.07% 367 NS July 31, 2026 N-PORT
IWC · iShares Trust 0.04% 37,870 SH Sept. 11, 2026 Daily
VDC · VANGUARD WORLD FUND 0.03% 128,565 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.02% 9,639 SH Aug. 19, 2026 Daily
DFSV · Dimensional ETF Trust 0.02% 67,386 NS July 31, 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 24,234 SH Oct. 1, 2026 Daily
DFAT · Dimensional ETF Trust 0.01% 67,428 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 64,278 SH Aug. 19, 2026 Daily
RSSL · Global X Funds 0.01% 5,337 NS July 31, 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0.01% 1,189 SH Oct. 1, 2026 Daily
DFAS · Dimensional ETF Trust 0.01% 42,099 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.01% 283,783 SH Sept. 11, 2026 Daily
DFAC · Dimensional ETF Trust 0.00% 19,278 NS July 31, 2026 N-PORT
ITOT · iShares Trust 0.00% 22,756 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 3,720 SH Sept. 3, 2026 Daily
DFUS · Dimensional ETF Trust 0.00% 1,784 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 124,681 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 350,035 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 790 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 101,470 SH Sept. 11, 2026 Daily
SMLF · iShares Trust · 22,964 SH Sept. 11, 2026 Daily

USNA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 6 analysts SELL
Median target $25.00 +68.7%
0 0.0% Strong Buy
0 0.0% Buy
3 50.0% Hold
1 16.7% Sell
2 33.3% Strong Sell

12-Month Price Target

1 analysts · 2026-10-01

Mean target $25.00 +68.7%

Low$25.00 Mean$25.00 High$25.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
EPC $946M 38.4 -1.3% 1.1% 1.7% 41.6%
BRBR $4.39B 21.6 16.1% 9.3% -72.0% 33.3%
HNST $291M -18.4 -1.9% -4.2% -8.8% 33.3%
NUS · 3.0 -14.3% 10.8% 22.0% 69.5%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 13, 2026